Blank
Al-Azhar University – Gaza
2024
Neurological Sciences
Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis
45
11
5261
5270
Springer-Verlag Italia s.r.l.
Faculty of Medicine, Cairo University, Cairo, Egypt; Faculty of Medicine, Alexandria University, Alexandria, Egypt; Faculty of Medicine, Mansoura University, Mansoura, Egypt; Faculty of Medicine, Al- Al-Azhar University, Gaza, Palestine; Faculty of Medicine, October 6Th University, Cairo, Egypt; Faculty of Medicine, Al-Azhar University, Damietta, Egypt
10
10.1007/s10072-024-07583-9
Alzheimer Disease; Humans; Phosphodiesterase 5 Inhibitors; Vardenafil Dihydrochloride; phosphodiesterase V inhibitor; sildenafil; tadalafil; vardenafil; phosphodiesterase V inhibitor; vardenafil; adult; aged; Alzheimer disease; Article; Cochrane Library; Embase; erectile dysfunction; female; human; male; Medline; meta analysis; middle aged; neuroprotection; Preferred Reporting Items for Systematic Reviews and Meta-Analyses; prostate cancer; prostate hypertrophy; risk; risk reduction; Scopus; sex difference; systematic review; Web of Science; drug therapy; epidemiology